5 Key Takeaways

• 1

  The study identified three distinct trabecular meshwork cell subtypes, revealing significant cellular diversity and specialization.

• 2

  A specific cell subtype, TM3, is metabolically vulnerable and linked to intraocular pressure elevation in a glaucoma mouse model.

• 3

  Vitamin B3 (nicotinamide) supplementation mitigates mitochondrial dysfunction in TM3 cells, preventing glaucoma-related pressure elevation.

• 4

  The findings suggest that therapies targeting cellular metabolism, like nicotinamide, could serve as new treatments for glaucoma.

• 5

  Future research will compare mouse TM cell subtypes to human counterparts to identify potential therapeutic targets for glaucoma.